People · Operator
Named in public records as an officer, director or promoter · active 2013–2014 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Pinta Biotherapeutics, Inc. | — | Biotechnology | Series B | $24.3M | $250.5M | 2013 |
| Santa Maria Biotherapeutics, Inc. | — | Biotechnology | Series B | $24.3M | $250.5M | 2013 |
| Nina Biotherapeutics, Inc. | — | Biotechnology | Seed | $3.4M | $39.0M | 2013 |
Gad F. Soffer at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Gad F. Soffer on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Isaac Ciechanover | 3 | 5 |
| Beth F. Seidenberg | 3 | 4 |
| Eckard F. Weber | 3 | 4 |
| Carol F. Gallagher | 3 | 4 |
| Joel F. Marcus | 3 | 3 |
| Christopher F. Haqq | 3 | 3 |
| John F. McGrath | 3 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.